PPARA and neoplasm: Once activated, PPARα translocates into the nucleus, and then binds to the PPAR response element (PPRE) in the promotor of the Cyp2c44 gene and reduces its expression, thereby indicating why PPARα agonists inhibit angiogenic activity and tumour vascularization [12, 13].